Neuphoria Therapeutics Inc 的股价在盘后交易时段录得显著上涨，涨幅达到6%，最终报收于4.85美元。值得注意的是，此次上涨是在交易量相对清淡的背景下发生的。与此同时，该公司正式确认，目前正与生物制药公司Scancell就一项潜在的收购交易进行谈判。这一消息的公布，为股价在非主要交易时段的波动提供了直接的市场解释。
Neuphoria Therapeutics Inc 的股价在盘后交易时段录得显著上涨，涨幅达到6%，最终报收于4.85美元。值得注意的是，此次上涨是在交易量相对清淡的背景下发生的。与此同时，该公司正式确认，目前正与生物制药公司Scancell就一项潜在的收购交易进行谈判。这一消息的公布，为股价在非主要交易时段的波动提供了直接的市场解释。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.